Atossa Therapeutics
ATOS
#10642
Rank
โ‚ฌ24.89 M
Marketcap
2,50ย โ‚ฌ
Share price
8.59%
Change (1 day)
175.70%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -โ‚ฌ32.45 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ31.21 Million a decrease over its 2024 earnings that were of -โ‚ฌ22.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ32.45 Million3.96%
2025 -โ‚ฌ31.21 Million36.33%
2024 -โ‚ฌ22.89 Million-15.25%
2023 -โ‚ฌ27.01 Million11.62%
2022 -โ‚ฌ24.2 Million30.84%
2021 -โ‚ฌ18.5 Million15.58%
2020 -โ‚ฌ16.01 Million3.41%
2019 -โ‚ฌ15.48 Million51.16%
2018 -โ‚ฌ10.24 Million40.41%
2017 -โ‚ฌ7.3 Million27.54%
2016 -โ‚ฌ5.72 Million-47.49%
2015 -โ‚ฌ10.89 Million-17.25%
2014 -โ‚ฌ13.16 Million35.91%
2013 -โ‚ฌ9.68 Million112.3%
2012 -โ‚ฌ4.56 Million46.53%
2011 -โ‚ฌ3.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ23.52 B-69,600.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ1.26 B-3,823.25%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ1.31 B-3,974.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚ฌ37.4 M-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚ฌ46.64 Million 37.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚ฌ7.04 Million-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA